These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 23962937)
21. [Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol]. Guy JM; André-Fouet X; Porte J; Bertrand M; Lamaud M; Verneyre H Ann Cardiol Angeiol (Paris); 1991 Nov; 40(9):541-5. PubMed ID: 1776799 [TBL] [Abstract][Full Text] [Related]
22. Droperidol-induced proarrhythmia: the beginning of an answer? Charbit B; Funck-Brentano C Anesthesiology; 2007 Oct; 107(4):524-6. PubMed ID: 17893444 [No Abstract] [Full Text] [Related]
26. [Erythrocyte-induced "torsade de pointes" ventricular tachycardia]. Lengyel C; Várkonyi T; Fazekas T Orv Hetil; 1997 Apr; 138(16):1003-6. PubMed ID: 9153994 [TBL] [Abstract][Full Text] [Related]
27. [Torsades-de-pointes-type ventricular tachycardia in a patient with digitalis intoxication under chronic treatment with quinine sulfate]. Ramírez A; Galván JM Med Intensiva; 2007 Mar; 31(2):106-7. PubMed ID: 17433191 [No Abstract] [Full Text] [Related]
28. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs). Lu HR; Yan GX; Gallacher DJ J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247 [TBL] [Abstract][Full Text] [Related]
30. The association between intravenous haloperidol and Torsades de Pointes. Three cases and a literature review. Hunt N; Stern TA Psychosomatics; 1995; 36(6):541-9. PubMed ID: 7501784 [TBL] [Abstract][Full Text] [Related]
31. Warning to "Refeeding syndrome". Torsades de pointes and ventricular tachyarrhythmia with marked QT prolongation induced by acute glucose injection: report of two cases. Inoue T; Doi T; Beppu K; Sasaki Y; Takeda S; Watanabe C; Shirasaka A; Kakio T; Hashimoto T; Kawai C; Kida Y; Nishina N; Esato M Int J Cardiol; 2012 Apr; 156(2):222-4. PubMed ID: 22341754 [No Abstract] [Full Text] [Related]
32. Coronary artery spasm as a cause of droperidol-induced ventricular fibrillation. Miyai N; Kawasaki T; Sugihara H; Kayo R Anesth Analg; 2006 Dec; 103(6):1602-3. PubMed ID: 17122267 [No Abstract] [Full Text] [Related]
33. A type 2 ryanodine receptor variant associated with reduced Ca Fujii Y; Itoh H; Ohno S; Murayama T; Kurebayashi N; Aoki H; Blancard M; Nakagawa Y; Yamamoto S; Matsui Y; Ichikawa M; Sonoda K; Ozawa T; Ohkubo K; Watanabe I; Guicheney P; Horie M Heart Rhythm; 2017 Jan; 14(1):98-107. PubMed ID: 27756708 [TBL] [Abstract][Full Text] [Related]
34. Is dolasetron the only possible culprit? Pivalizza EG J Clin Anesth; 2008 Sep; 20(6):478. PubMed ID: 18929294 [No Abstract] [Full Text] [Related]
35. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature. Lawrence KR; Nasraway SA Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555 [TBL] [Abstract][Full Text] [Related]
36. Droperidol--has it suffered a fatal wound? Berry FA Paediatr Anaesth; 2004 Oct; 14(10):807-9. PubMed ID: 15385007 [No Abstract] [Full Text] [Related]